Feliza Mirasol is the science editor for 

Articles

Lonza’s new GS Effex cell line can help overcome the challenges of developing therapeutic antibodies with increased potency.

Lonza Launches New Cell Line for Higher Potency Antibody Development

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

The 3M Harvest RC Chromatographic Clarifier, BT500 is the latest addition to the company’s chromatographic clarifier portfolio.

3M Health Care Launches New Chromatographic Clarifier

Novartis and Legend Biotech seek to advance certain CAR-T cell therapy candidates targeting Delta-like ligand protein 3.

Novartis and Legend Biotech Sign Exclusive License Agreement for CAR-T Therapies

Adzynma provides a replacement for low levels of the ADAMTS13 enzyme in patients with congenital thrombotic thrombocytopenic purpura.

FDA Approves First Recombinant Treatment for Rare Blood Clotting Disorder

Chris Spivey is the editorial director of 

A discussion with Thomas Langenickel, MD, chief medical officer at Ethris, shines a light on how advances made with mRNA technology are also advancing the industry’s ability to focus on treatment of rare diseases, such as rare lung diseases.

mRNA Advances Allow Drug Development Focus on Rare Diseases (Part One)

Aitia will access Charles River’s Logica drug solution platform to develop therapeutic programs for neurodegenerative disease and oncology.

Charles River Laboratories and Aitia Partner on Neurodegenerative Disease and Oncology Drug Development

Recommended medicines include treatments for generalized myasthenia gravis, glioma, neovascular age-related macular degeneration, and more.

EMA Recommends Rare Blood Cancer Treatment and Seven Other Medicines

Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field.

Discussing the Origins of the mRNA Therapeutics Field (Part One)

Electronic product information for selected human medicines that have been harmonized across the European Union have been published for the first time.

Europe Publishes Electronic Product Information for Selected Medicines

The document includes recommendations for the reporting and implementation of changes to container closure system components.

All News